(object) array( 'id' => '1467656', 'url' => 'SR/Lamisil', 'image' => '', 'title' => 'Lamisil', 'tags' => array ( 0 => 'Lamisil', 1 => 'Pharmaceutical', 2 => '', ), 'term' => 'Lamisil', 'source_id' => 31149, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'lastedit' => '20110709210504', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'antibiotik koji se koristi u lečenju gljivičnog oboljenja noktiju na prstima stopala', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999385845762, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'Lamisil', 'Definition' => 'an antibiotic used to treat toenail fungus', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Industry' => 'Pharmaceutical', 'Revision User' => 'PetriDish', 'Revision Date' => '2010/05/26', 'Creation User' => 'PetriDish', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'Lamisil', )

(object) array( 'id' => '1467647', 'url' => 'SR/study_type', 'image' => '', 'title' => 'tip studje', 'tags' => array ( 0 => 'tip studje', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'tip studje', 'source_id' => 30943, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110709204525', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Primarne tehnike ispitivanja korišćene u protokolu observacije; tipovi su Svrha, Trajanje, Selekcija i Tajming', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603999174033410, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'study type', 'Definition' => 'The primary investigative techniques used in an observational protocol; types are Purpose, Duration, Selection, and Timing.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'study_type', )

(object) array( 'id' => '1461003', 'url' => 'SR/data_safety_and_monitoring_board_(dsmb)', 'image' => '', 'title' => 'Odbor za bezbednost podataka i monitoring', 'tags' => array ( 0 => 'Odbor za bezbednost podataka i monitoring', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'Odbor za bezbednost podataka i monitoring', 'source_id' => 30887, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152003', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Nezavisni odbor koji se sastoji od predstavnika udruženja i stručnjaka za klinička ispitivanja koji vrše pregled podataka u toku samog kliničkog ispitivanja radi sigurnosti da učestnici nisu izloženi nepotrebnom riziku. ovaj Odbor(DSMB)može predložiti okončanje ispitivanja ukoliko postoji sumnja u bezbedenost iii ukoliko su ciljevi ispitivanja postignuti.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907777, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'data safety and monitoring board (dsmb)', 'Definition' => 'An independent committee, composed of community representatives and clinical research experts, that reviews data while a clinical trial is in progress to ensure that participants are not exposed to undue risk. A DSMB may recommend that a trial be stopped if there are safety concerns or if the trial objectives have been achieved.', 'Synonym' => 'DSMB_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'data_safety_and_monitoring_board_(dsmb)', )

(object) array( 'id' => '1461301', 'url' => 'SR/benefits', 'image' => '', 'title' => 'benefit', 'tags' => array ( 0 => 'benefit', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'benefit', 'source_id' => 40068, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705222505', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'posebne povoljnosti za zaposlene npr. plaćeno zdravstveno osiguranje', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967781765120, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'benefits', 'Definition' => 'Extra advantages offered to employees e.g. paid health insurance.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'benefits', )

(object) array( 'id' => '1461004', 'url' => 'SR/double-blind_study', 'image' => '', 'title' => 'duplo-slepa studija', 'tags' => array ( 0 => 'duplo-slepa studija', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'duplo-slepa studija', 'source_id' => 30890, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705152004', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Klinička studija u kojoj ni pojedinci koji u njoj učestvuju ni stručna lica koja studiju sprovode ne znaju koji ispitanici dobijaju eksperimentalni lek a koji placebo(ili drugu terapiju). Smatra se da duplo-slepa studija daje objektivne rezultate, pošto očekivanja lekara i ispitanika vezana za eksperimentalni lek ne utiču negativno na sam ishod:poznata još pod nazivom duplo-maskirana studija. Vidi slepa-studija,jednostruko-slepa studija i placebo', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603966424907778, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'double-blind study', 'Definition' => 'A clinical trial design in which neither the participating individuals nor the study staff knows which participants are receiving the experimental drug and which are receiving a placebo (or another therapy). Double-blind trials are thought to produce objective results, since the expectations of the doctor and the participant about the experimental drug do not affect the outcome; also called double-masked study. See Blinded Study, Single-Blind Study, and Placebo.', 'Synonym' => 'double-masked study_₀', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'double-blind_study', )

(object) array( 'id' => '1461306', 'url' => 'SR/employee_handbook', 'image' => '', 'title' => 'Informator za zaposlene', 'tags' => array ( 0 => 'Informator za zaposlene', 1 => 'Business services', 2 => 'Human resources', 3 => '', ), 'term' => 'Informator za zaposlene', 'source_id' => 40079, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Human resources', ), 'lastedit' => '20110705222511', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Vodič za zaposlene koji sadrži informacije o kompaniji, uslovima i odredbama, politici i procedurama kompanije.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967781765125, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'employee handbook', 'Definition' => 'A guide for employees including information about the company, terms and conditions, and policies and procedures in the company.', 'Part of Speech' => 'noun', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Product Category' => 'Human resources', 'Industry' => 'Business services', 'Revision User' => 'Robert Derbyshire', 'Revision Date' => '2010/6/8', 'Creation User' => 'Robert Derbyshire', 'Creation Date' => '2010/6/8', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'employee_handbook', )

(object) array( 'id' => '1460564', 'url' => 'SR/cohort', 'image' => '', 'title' => 'kohorta', 'tags' => array ( 0 => 'kohorta', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'kohorta', 'source_id' => 30879, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705074506', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'U epidemiologiji, grupa pojedinaca sa nekim sličnim karakteristikama.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964534325250, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'cohort', 'Definition' => 'In epidemiology, a group of individuals with some characteristics in common.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'cohort', )

(object) array( 'id' => '1461319', 'url' => 'SR/price_floor', 'image' => '', 'title' => 'minimalna cena', 'tags' => array ( 0 => 'minimalna cena', 1 => 'Business services', 2 => 'Marketing', 3 => '', ), 'term' => 'minimalna cena', 'source_id' => 54607, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Business services', ), 'category' => array ( 0 => 'Marketing', ), 'lastedit' => '20110705225507', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Minimalni iznos koji se moe naplatiti prema vrednosti proizvoda ili zakonskim restrikcijama.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603967783862278, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'price floor', 'Definition' => 'The minimum amount that can be charged due to product cost or law restrictions.', 'Domain' => 'Documentation', 'Industry' => 'Business services', 'Part of Speech' => 'noun', 'Product Category' => 'Marketing', 'Usage Status' => 'New', 'Revision User' => 'Acrovo', 'Revision Date' => '2010/6/17', 'Creation User' => 'Acrovo', 'Creation Date' => '2010/6/17', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'price_floor', )

(object) array( 'id' => '1460563', 'url' => 'SR/approved_drugs', 'image' => '', 'title' => 'odobreni lekovi', 'tags' => array ( 0 => 'odobreni lekovi', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'odobreni lekovi', 'source_id' => 30872, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705074505', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'U Sjedinjenim Državama, Zavod za zaštitu zdravlja (FDA) mora odobriti supstancu kao lek pre nego bude pušten na tržište. Ovaj proces podrazumeva nekoliko stadijuma uključujući prekliničke laboratorijske studije i studije na životinjama, kliničko testiranje bezbednosti i efikasnosti proizvoda, popunjavanje Prijuave za registraciju novog leka od strane proizvođača samog leka, pregled prijave od strane FDA i odobrenje/odbijanje prijave od strane FDA', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964534325249, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'approved drugs', 'Definition' => 'In the U.S., the Food and Drug Administration (FDA) must approve a substance as a drug before it can be marketed. The approval process involves several steps including pre-clinical laboratory and animal studies, clinical trials for safety and efficacy, filing of a New Drug Application by the manufacturer of the drug, FDA review of the application, and FDA approval/rejection of application.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'approved_drugs', )

(object) array( 'id' => '1460609', 'url' => 'SR/confidentiality_regarding_trial_participants', 'image' => '', 'title' => 'poverljivost podataka učesnika u kliničkom ispitivanju', 'tags' => array ( 0 => 'poverljivost podataka učesnika u kliničkom ispitivanju', 1 => 'Pharmaceutical', 2 => 'Clinical trials', 3 => '', ), 'term' => 'poverljivost podataka učesnika u kliničkom ispitivanju', 'source_id' => 30883, 'type' => 'term', 'namespace' => 1836, 'nstext' => 'SR', 'industry' => array ( 0 => 'Pharmaceutical', ), 'category' => array ( 0 => 'Clinical trials', ), 'lastedit' => '20110705083507', 'part_of_speech' => 'noun', 'creation_user' => 'Ena Slavkovic', 'special_term' => '', 'definition' => 'Odnosi se na poštovanje poverljivosti podataka učesnika u kliničkom ispitivanju uključujući njihov identitet i sve lične medicinskwe informacije. Odobrenje za korišćenje dobijenih podataka radi verifikacije samih podataka mora unapred biti dobijeno od učesnika ispitivanja kao i uverenje da poverljivost mora biti zagarantovana.', 'usage_comment' => '', 'glossary' => '', 'width' => 0, 'height' => 0, '_version_' => 1503603964695805952, 'nstext_full' => 'Serbian (SR)', 's_attr' => (object) array( 'Term' => 'confidentiality regarding trial participants', 'Definition' => 'Refers to maintaining the confidentiality of trial participants including their personal identity and all personal medical information. The trial participants\' consent to the use of records for data verification purposes should be obtained prior to the trial and assurance must be given that confidentiality will be maintained.', 'Part of Speech' => 'noun', 'Industry' => 'Pharmaceutical', 'Product Category' => 'Clinical trials', 'Domain' => 'Documentation', 'Usage Status' => 'New', 'Revision User' => 'Hkdoc9', 'Revision Date' => '2010/05/26', 'Creation User' => 'Hkdoc9', 'Creation Date' => '2010/05/26', 'Source Lang' => '1180', ), 's_namespace_text' => 'EN', 's_namespace_text_full' => 'English (EN)', 's_title' => 'confidentiality_regarding_trial_participants', )